Kurse + Charts + RealtimeNews + AnalysenFundamentalUnternehmenzugeh. WertpapiereAktion
Kurs + ChartChart (groß)NewsBilanz/GuVDividende/HVZertifikateDepot/Watchlist
Times + SalesChart-AnalyseAnalysenSchätzungenTermineOptionsscheinemyHome
BörsenplätzeChartvergleichKursziele ProfilKnock-OutsSenden
OrderbuchRealtime Stuttgart  InsidertradesFonds 
HistorischRealtime PushmyNews im ForumAnleihen
Kaufen
Verkaufen
  • Sprache:
  • Alle
  • DE
  • EN
  • Sortieren:
  • Datum
  • meistgelesen
16.04.14
BioAlliance Pharma and Topotarget Enter into Merger Agreement to Create a Leading Orphan Oncology Company (Businesswire)
14.04.14
BioAlliance Pharma Announces a New Positive DSMB Recommendation to Continue Its Phase III Clinical Trial with Livatag® in Primary Liver Cancer (Businesswire)
08.04.14
BioAlliance Pharma Announces Shareholders’ Meeting and Approval of all resolutions (Businesswire)
08.04.14
BioAlliance Pharma SA : Publication of the 2013 Registration Document (Businesswire)
03.04.14
BioAlliance Pharma : Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at March 31, 2014 (Businesswire)
02.04.14
BioAlliance Pharma signs a new licensing agreement with Daewoong Pharmaceutical Co., Ltd. for Sitavig®’s commercialization in South Korea (Businesswire)
01.04.14
BioAlliance Pharma provides an update on its partnerships for Loramyc®/Oravig® (Businesswire)
31.03.14
BioAlliance Pharma Collaborates with Penn Pharma on the Industrial Development of Validive® (Businesswire)
28.03.14
BioAlliance Pharma announces participation in the Smallcap Event On April 7th and 8th 2014 in Paris (Hugin)
28.03.14
BioAlliance Pharma Announces Participation in the Smallcap Event on April 7th and 8th 2014 in Paris (Businesswire)
19.03.14
BioAlliance Pharma: Sitavig® Licensing Strategy (Businesswire)
27.02.14
BioAlliance Pharma Provides Updates on Its Major Achievements and Reports 2013 Consolidated Financial Results (Businesswire)
18.02.14
BioAlliance Pharma SA: Strengthening and extension of the industrial protection of Livatag® until 2031 (Businesswire)
05.02.14
BioAlliance Pharma : Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at January 31, 2014 (Businesswire)
04.02.14
BioAlliance Pharma’s Partner, Sosei, Announces a Partnership With FUJIFILM Pharma for Commercialization Rights for Loramyc® in Japan (Businesswire)
23.01.14
BioAlliance Pharma : FDA Grants Validive® (clonidine Lauriad®) with a Fast Track Designation for the Prevention and Treatment of Oral Mucositis Induced by Anticancer Treatments (Businesswire)
13.01.14
BioAlliance Pharma : Disclosure of total number of voting rights and number of shares in the capital at December 31, 2013 (Businesswire)
04.12.13
BioAlliance Pharma: Approval to start ReLive (Livatag®) Phase III Clinical Trial in Primary Liver Cancer in the U.S. and Germany (Businesswire)
04.12.13
BioAlliance Pharma : Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at November 30, 2013 (Businesswire)
14.11.13
BioAlliance Pharma : Quarterly information as of September 30, 2013 (Businesswire)
14.11.13
BioAlliance Pharma Strengthens Sitavig Patent Protection with New U.S. and South Korean issued Patents (Businesswire)
06.11.13
BioAlliance Pharma : Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at October 31, 2013 (Businesswire)
22.10.13
BioAlliance Pharma Announces Third Positive DSMB Recommendation to Continue Its Phase III Clinical Trial with Livatag® in Primary Liver Cancer (Businesswire)
22.10.13
BioAlliance Pharma launches its new website (Businesswire)
07.10.13
BioAlliance Pharma : Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at September 30, 2013 (Businesswire)
30.09.13
BioAlliance Pharma : First Meeting of the International Advisory Board on Oral Mucositis and Development of Validive® (Businesswire)
19.09.13
BioAlliance Pharma: Key milestones and consolidated accounts (Businesswire)
05.09.13
BioAlliance Pharma : Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at August 31, 2013 (Businesswire)
02.08.13
BioAlliance Pharma: Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at July 31, 2013 (Businesswire)
10.07.13
BioAlliance Pharma Expands and Strengthens Its Industrial Property Assets with Two Patent Grants (Businesswire)
03.07.13
BioAlliance Pharma Receives €4.3 Million in Funding from bpifrance (ex OSEO) To Accelerate the Industrial Development of Livatag(R) (Businesswire)
27.06.13
BioAlliance Pharma Announces Shareholders’ Meeting and Appointment of Russell Greig and Danièle Guyot-Caparros as Independant Board Members (Businesswire)
10.06.13
BioAlliance Pharma Announces the Initiation of the Phase II Clinical Trial with Validive® in the United States (Businesswire)
06.06.13
BioAlliance Pharma : Disclosure of Total Number of Voting Rights and Number of Shares in the Capital at May 31, 2013 (Businesswire)
05.06.13
BioAlliance Pharma : Combined Ordinary and Extraordinary General Meeting on June 26th 2013 (Businesswire)
27.05.13
BioAlliance Pharma presents results on Sitavig® at the 10th EADV symposium (Businesswire)
14.05.13
BioAlliance Pharma : Disclosure of total number of voting rights and number of shares in the capital at April 30, 2013 (Businesswire)
13.05.13
BioAlliance Pharma announces DSMB second positive recommendation to continue its Phase III clinical trial with Livatag® in primary liver cancer (Businesswire)
19.04.13
BioAlliance Pharma SA : Publication of the 2012 Registration Document (Businesswire)
15.04.13
BioAlliance Pharma Updates on Major Achievements of 2012 and Publishes Its 2012 Consolidated Financial Statements and Income for Q1 2013 (Businesswire)
Seite: 1234

Bioalliance PharmaAct Nom Cat-P News

Bioalliance PharmaAct Nom Cat-P News: auf dieser Seite finden Sie alle Bioalliance PharmaAct Nom Cat-P News und Nachrichten zur Bioalliance PharmaAct Nom Cat-P Aktie. Dies beinhaltet die Agentur-Feeds auf finanzen.net, aber auch Bioalliance PharmaAct Nom Cat-P News auf einer Vielzahl externer Seiten. Externe Links sind am entsprechenden Link-Symbol zu erkennen. Um Bioalliance PharmaAct Nom Cat-P News auf externen Seiten zu lesen, folgen Sie einfach dem entsprechenden Link.

Meistgelesene Bioalliance PharmaAct Nom Cat-P News 1M

Bioalliance PharmaAct Nom Cat-P Peer Group News

Keine Nachrichten gefunden.